AnaptysBio, Inc. (ANAB)

NASDAQ: ANAB · Real-Time Price · USD

47.94

+2.51 (5.52%)

At close: Oct 21, 2026, 4:00 PM EDT

47.67

-0.27 (-0.56%)

After-hours: Oct 21, 2026, 7:40 PM EDT

AnaptysBio Financials Overview

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	106.09	106.09	234.6	91.28	17.16	10.29
Revenue Growth	-13.86%	-54.78%	157.01%	432.03%	66.78%	-83.72%
Gross Profit	111.42	111.42	238.25	79.79	-115.13	-78.51
Operating Income	65.7	65.7	226.9	66.15	-157.07	-115.15
Net Income	261.99	261.99	-13.23	-145.23	-163.62	-128.72
Earnings Per Share	7.00	7.00	-0.44	-4.91	-6.08	-4.57
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	164.14	164.14	211.64	285.37	390.9	441.24
Total Debt	269.59	269.59	290.64	369.46	328.62	323.86
Net Cash (Debt)	-105.45	-105.45	-79	-84.09	62.28	117.38
Net Cash Growth	-	-	-	-	-46.94%	-57.48%
Net Cash Per Share	-2.81	-2.81	-2.61	-2.85	2.31	4.17

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-105.12	-105.12	19.7	-135.34	-120.8	-73.59
Capital Expenditures	-	-	-	-	-0.81	-0.36
Free Cash Flow	-105.12	-105.12	19.7	-135.34	-121.61	-73.95
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	105.03%	105.03%	101.55%	87.41%	-	-
Operating Margin	61.93%	61.93%	96.72%	72.47%	-915.50%	-1119.41%
Pretax Margin	-9.60%	-9.60%	69.17%	34.11%	-953.68%	-1251.09%
Profit Margin	246.96%	246.96%	-5.64%	-159.11%	-953.66%	-1251.33%
FCF Margin	-99.09%	-99.09%	8.40%	-148.27%	-708.79%	-718.88%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 22, 2026	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	6.85	7.63	-	-	-	-
Forward PE	13.48	37.90	14.68	14.68	14.68	14.68
P/FCF Ratio	-	-	68.15	-	-	-
PS Ratio	13.49	18.84	5.72	4.41	33.18	85.65